Dual Incretin Peptide Analog
Tirzepatide is a fatty-acid-modified GIP/GLP-1 receptor agonist peptide analog represented in incretin-pathway research.
Product Procurement
Research-use catalog items with clear ordering, product context, and documentation support.
Tirzepatide — 60mg
$199.99
- FORMAT
- Lyophilized Powder
- STRENGTH
- 60mg
- CATEGORY
- Peptides
- SKU
- ALS-TIRZ-60MG
Research Use Notice
For laboratory research use only. Not for human or veterinary use, food, drug, cosmetic, or household use.
Product Intelligence
Tirzepatide Receptor & Peptide Profile
Fatty-acid-modified incretin peptide research material supplied as 60mg lyophilized tirzepatide.
60mg Lyophilized Tirzepatide
Supplied as 60mg lyophilized tirzepatide research material.
GIP / GLP-1 Receptor Context
Tirzepatide appears in receptor-pathway research involving GIP receptor pharmacology, GLP-1 receptor pharmacology, receptor-binding models, and cell-signaling assays.
- ClassGIP/GLP-1 receptor agonist peptide analog
- IdentifierPubChem CID 166567236
- Presentation60mg lyophilized material
Documentation
Verification & Documentation
Documentation is handled by product and lot. Use Standards to search for a matching record; if none appears, contact support with the product name, SKU, and lot number.
